RecruitingNot ApplicableNCT05601037
LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema
Lymfo-Veneuse Anastomosen Ter Preventie Van Lymphoedeem
Sponsor
University Hospital, Ghent
Enrollment
80 participants
Start Date
Jun 30, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
Lymphedema is defined as a chronic condition, caused by lymphostasis. A major part in the Western world consists of iatrogenic lymphedema caused by surgery to the lymph nodes of the axilla or groin. Prophylactic lymphovenous anastomosis (LVA) could be beneficial in the prevention of lymphedema of the extremities.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 99 Years
Inclusion Criteria1
- lymph node + breast cancer requiring dissection
Exclusion Criteria2
- previous lymphedema
- BMI \>35
Interventions
PROCEDUREAxilla dissection + Lymphovenous anastomosis
surgical bypass between lymphatic vessel and vein
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05601037
Related Trials
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
NCT053666991 location
Gentle Touch for Post-Mastectomy Lymphedema
NCT072576792 locations
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT0589067735 locations
The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related Lymphedema
NCT065329551 location
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
NCT048889751 location